Clinical Trial Update: A Prospective, Single-Arm Study to Evaluate the Efficacy and Safety of Zoladex 3.6mg Combined With CEF Chemotherapy as Neo-Adjuvant Therapy in Hormone Responsive, Premenopausal, Operable Breast Cancer [NA]

View source ↗

Summary

This clinical trial update describes a prospective, single-arm study evaluating the efficacy and safety of Zoladex 3.6 mg combined with CEF chemotherapy as neoa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Epirubicin (epirubicin)
• Zoladex 3.6 mg (goserelin)

Snippet

Sponsor: Tianjin Medical University | Conditions: Breast Cancer | NA | Status: UNKNOWN